Efficacy of lapatinib in patients with high tumor EGFR expression: Results of a phase III trial in advanced renal cell carcinoma (RCC)
Alain Ravaud(Bordeaux Population Health), I. El-Hariry(Aarhus University Hospital), Robert D. Hawkins(University of Manchester), Jason P. Gardner(Aarhus University Hospital), Jean-Pascal Machiels(Cliniques Universitaires Saint-Luc), Niko Zantl(Aarhus University Hospital), F. Rolland(Institut de Cancérologie de l'Ouest), Hans von der Maase(University of Copenhagen), P. Harper(Aarhus University Hospital), B. Audhuy(Aarhus University Hospital)
Cited by 58
Related Papers
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
|Journal of Clinical Oncology|2000|2.3k
Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer
|Journal of Clinical Oncology|2005|1.9k
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803